In 2023 Macedonia started the procedure for a pilot study.

The Medical faculty-Skopje, Institute of immunology and human genetics were launching a pilot program in December 2023 for spinal musculat atrophy (SMA) in collaboration with and support by pharmaceutical companies and their own sources from the budget of Medical faculty-Skopje.

June 2024: Confirmation and approval from Ministry of Health-Skopje received, that Institut of imunology and human genetics - Skopje is ready to start the pilot program.

Now a pilot program Macedonia is active.

NBS is now availabel but only for the region of Skopje, which means that around 9.000 babies will be tested each year as a part of the pilot program.

Contact person: Prof. Dr. Aleksandar Petlichkovski, Head of the Center for immune, molecular and genetic investigations, Institute for immunology and human genetics - Medical faculty - Skopje.

email: aleksandar.petlichkovski@medf.ukim.edu.mk

Population; 1,836,713 (2022)

Live births: 18,648 (2021)

Disorders in national neonatal screening programme: 25 + 1 (2021)

Percentage of newborns screened for SMA: 0%